Transforming Cytopathology Workflow
Our tools turn cytopathology from a slow and manual process into a fast and AI-powered one. Cytotechnicians and pathologists used to spend hours to manually review limited fields of view; now they can access ALL fields of view in seconds. They used to rely on qualitative descriptions; now they can instantly obtain quantitative scoring across whole samples.
Discovering clinical insights has never been easier.
Benefiting Key Stakeholders
Providers
- Minimize repetitive workload
- Decentralization
- Accurate diagnostics
Payers
- Cost effective
- Quality of care
Patients
- Minimally invasive
- Rapid results for improved outcomes
- Improved outcomes
Our Platform Targets Three of the Top Cancers
Our platform is currently being used to address three of the top cancers in the United States.
exfoliative
Urine Cytology
(Bladder Cancer)
- 4th in men
- 81,400 new cases (est. 2020)
- 17,980 deaths (est. 2020)
abrasive
Cervical Cytology
(Pap Smear)
- 4th in women
- 13,800 new cases (est. 2020)
- 4,290 deaths (est. 2020)
aspirational
Thyroid Cytology
(Fine Needle Aspiration)
- 5th in women
- 52,890 new cases (est. 2020)
- 2,180 deaths (est. 2020)